Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
12.02
+0.53 (4.57%)
Apr 24, 2025, 2:11 PM EDT - Market open
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $3.10 billion as of April 24, 2025. Its market cap has decreased by -33.24% in one year.
Market Cap
3.10B
Enterprise Value
11.41B
1-Year Change
-33.24%
Ranking
Category
Stock Price
$12.02
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $3.10B, a decrease of -63.18%. That is a compound annual growth rate of -22.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 2.96B | -22.87% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.57B |
| UnitedHealth Group | 389.05B |
| Johnson & Johnson | 378.15B |
| AbbVie | 301.01B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |